MedDataX Logo

Walking Estimated Limitation Calculated by History - Study 2

NCT ID: NCT01424020

Last Updated: 2016-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test and validate a new questionnaire in order to get a "walking estimated limitation calculated by history (WELCH) in patients referred for vascular investigations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Two questionnaires the WELCH and the "walking impairment questionnaire" (WIQ) are submitted to patients referred for vascular investigations for suspêcted peripheral arterial disease (PAD). Comparison of score to hemodynamic parameters (first goal) or maximal walking distance (MWD) on treadmill (secondary goal). Scoring of the WIQ is performed according to references. Scoring of the WELCH has been submitted for copyright protection (involves a series of 4 additions a subtraction and a single multiplication)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Artery Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Questionnaire peripheral artery disease execise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

questionnaire

Patients suspected of peripheral artery disease and, as such, referred for a vascular investigations and submitted the WELCH questionnaire

Group Type EXPERIMENTAL

Questionnaire

Intervention Type OTHER

Self completed questionnaire, Supervised by the physician Ankle brachial index (ABI) calculation Maximal walking distance (MWD) on treadmill or over the 6 minutes walking test (when available)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Self completed questionnaire, Supervised by the physician Ankle brachial index (ABI) calculation Maximal walking distance (MWD) on treadmill or over the 6 minutes walking test (when available)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Walking impairment questionnaire (WIQ) Walking estimated limitation calculated by history (WELCH)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* French Native language
* 18 years old or older
* Signed consent
* Covered by the French social care system

Exclusion Criteria

* Unable to participate for administrative reasons
* Psychiatric troubles
* Pain at rest or critical limb ischemia
* Unable to walk (ex: wheelchair subjects)

Note: previous inclusion in the protocole is note an exclusion criterion for a new participation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre ABRAHAM, MD; PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital in Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vascular investigation

Angers, , France

Site Status RECRUITING

Vascular Medicine

Annecy, , France

Site Status RECRUITING

Vascular Medicine

Aubenas, , France

Site Status RECRUITING

Rehabilitation

Ballan-Miré, , France

Site Status RECRUITING

Vascular Medicine

Belfort, , France

Site Status RECRUITING

Vascular Medicine

Caen, , France

Site Status RECRUITING

Vascular Medicine

Castanet-Tolosan, , France

Site Status RECRUITING

Vascular Medicine

Champagnole, , France

Site Status RECRUITING

Vascular Medicine

Chazelles-sur-Lyon, , France

Site Status RECRUITING

Rehabilitation

Hauteville, , France

Site Status RECRUITING

Vascular Medicine

Paris, , France

Site Status RECRUITING

Vascular Medicine

Perpignan, , France

Site Status RECRUITING

Vascular Medicine

Périgueux, , France

Site Status RECRUITING

Vascular Medicine

Reims, , France

Site Status SUSPENDED

Vascular Medicine

Sallanches, , France

Site Status RECRUITING

Vascular Medicine

Tarbes, , France

Site Status RECRUITING

Vascular Medicine

Villenave-d'Ornon, , France

Site Status RECRUITING

Vascular Medicine

Wattrelos, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pierre Abraham, MD; PhD

Role: CONTACT

Phone: 33 (0) 2 41 35 36 89

Email: [email protected]

Johann Marchand, MD

Role: CONTACT

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHU-P 2011-06

Identifier Type: -

Identifier Source: org_study_id